Plus Therapeutics
在场
Plus Therapeutics 是一家在股票代码 CYTX (US) 下上市的公司。
高管
查看带有其 11 名主要高管的组织结构图
Plus Therapeutics 搜索最多的简介
- Marc Hedrick, President, Chief Executive Officer and Director
- Richard Hawkins, Chairman of the Board
- Robert Lenk, Director
创建提醒
跟踪 Plus Therapeutics 的高管变动
药店
Plus Therapeutics 拥有 1,971 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Roche (瑞士)。
Popular M&A news in 药店
- Cencora的新名称是Cencora。 (公布2023一月24号).
- Sun Pharma has announced the acquisition of Concert Pharmaceuticals (公布2023一月24号).
- SetPoint Medical 刚刚宣布为 80 筹款数百万美元。 (公布2023一月24号).
药店 行业的其他推荐联系人
消息
Plus Therapeutics 的最新新闻稿
- PLUS THERAPEUTICS, Inc. Press Releases Plus Therapeutics to Participate in Upcoming Virtual ConferencesPlus Therapeutics to Participate in Upcoming Virtual ConferencesPlus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Busine
- PLUS THERAPEUTICS, Inc. - News
- PLUS THERAPEUTICS, Inc. - News
- PLUS THERAPEUTICS, Inc. - Press Releases
- PLUS THERAPEUTICS, Inc. - News
- PLUS THERAPEUTICS, Inc. Press Releases Plus Therapeutics to Participate in Upcoming November Investor ConferencesPlus Therapeutics Announces Webinar to Present ReSPECT™ Glioblastoma Clinical Trial UpdatePlus Therapeutics Announces Formation of Scientific
- View more press releases Close
通过电子邮件
